PetMed Express Reports Director Changes and Officer Compensation Updates

Ticker: PETS · Form: 8-K · Filed: 2024-05-31T00:00:00.000Z

Sentiment: neutral

Topics: management-change, compensation

Related Tickers: PETS

TL;DR

PETS board shake-up and exec pay changes filed today.

AI Summary

PetMed Express, Inc. filed an 8-K on May 31, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing indicates a departure of directors and the election of new ones, along with updates to the compensatory arrangements for certain officers. Specific details regarding the individuals involved and the financial implications of these changes were not fully elaborated in the provided text but are typically included in such filings.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial priorities, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in directorship and executive compensation can indicate internal shifts that may affect company strategy and performance, warranting closer investor scrutiny.

Key Players & Entities

FAQ

What specific changes were made to the board of directors of PetMed Express, Inc.?

The filing indicates a departure of directors and the election of new directors, as per the 'Departure of Directors or Certain Officers; Election of Directors' item.

Were there any changes to the compensatory arrangements of certain officers at PetMed Express, Inc.?

Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers' as an item being reported.

On what date was this 8-K filing reported?

The report date for this 8-K filing is May 31, 2024.

What is the principal executive office address for PetMed Express, Inc.?

The principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the IRS Employer Identification Number for PetMed Express, Inc.?

The IRS Employer Identification Number for PetMed Express, Inc. is 65-0680967.

From the Filing

0001040130-24-000032.txt : 20240531 0001040130-24-000032.hdr.sgml : 20240531 20240531172441 ACCESSION NUMBER: 0001040130-24-000032 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240531 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240531 DATE AS OF CHANGE: 20240531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28827 FILM NUMBER: 241010895 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20240531.htm 8-K pets-20240531 0001040130 FALSE 0001040130 2024-05-31 2024-05-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  May 31, 2024 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 31, 2024, PetMed Express, Inc. (the “Company”) entered into a Transition and Separation Agreement (the “Agreement”) with Christine Chambers, the Company’s Chief Financial Officer, Treasurer, and Secretary, pursuant to which the Company and Ms. Chambers agreed to the mutual termination of Ms. Chambers’ employment with the Company following a transition period. Under the terms of the Agreement, the Company and Ms. Chambers mutually agreed to terminate the Executive Employment Agreement, dated August 3, 2022, between the Company and Ms. Chambers effective immed

View on Read The Filing